IRIS UniCatt

Bentivoglio, Anna Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.999
AS - Asia 10.362
EU - Europa 10.308
SA - Sud America 1.901
AF - Africa 287
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 16
Totale 35.906
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.639
SG - Singapore 4.434
DE - Germania 3.006
CN - Cina 2.462
IT - Italia 1.641
BR - Brasile 1.529
SE - Svezia 1.370
VN - Vietnam 1.170
FR - Francia 1.065
UA - Ucraina 872
GB - Regno Unito 530
IE - Irlanda 491
IN - India 400
FI - Finlandia 341
HK - Hong Kong 337
ID - Indonesia 305
RU - Federazione Russa 291
JP - Giappone 283
TR - Turchia 202
CA - Canada 171
BD - Bangladesh 155
AR - Argentina 147
NL - Olanda 139
PL - Polonia 127
MX - Messico 113
IQ - Iraq 112
ES - Italia 90
BE - Belgio 75
CI - Costa d'Avorio 70
ZA - Sudafrica 70
KR - Corea 69
AT - Austria 68
PK - Pakistan 58
EC - Ecuador 55
IR - Iran 46
SA - Arabia Saudita 46
VE - Venezuela 41
UZ - Uzbekistan 39
CO - Colombia 35
AU - Australia 29
PH - Filippine 29
CL - Cile 28
JO - Giordania 27
MA - Marocco 27
CH - Svizzera 26
CZ - Repubblica Ceca 24
IL - Israele 24
KE - Kenya 24
PY - Paraguay 23
LT - Lituania 22
AZ - Azerbaigian 19
BO - Bolivia 18
KZ - Kazakistan 18
RO - Romania 18
TN - Tunisia 18
AE - Emirati Arabi Uniti 16
EG - Egitto 16
BG - Bulgaria 14
DZ - Algeria 14
PE - Perù 13
CR - Costa Rica 12
EU - Europa 12
NP - Nepal 12
AL - Albania 11
ET - Etiopia 11
HU - Ungheria 11
PA - Panama 11
UY - Uruguay 11
MY - Malesia 10
OM - Oman 10
SN - Senegal 10
TT - Trinidad e Tobago 10
DK - Danimarca 9
GR - Grecia 9
JM - Giamaica 9
TH - Thailandia 9
TW - Taiwan 9
EE - Estonia 8
LB - Libano 8
PS - Palestinian Territory 8
PT - Portogallo 8
BY - Bielorussia 7
DO - Repubblica Dominicana 7
MD - Moldavia 7
NI - Nicaragua 7
HN - Honduras 6
LU - Lussemburgo 6
KG - Kirghizistan 5
KW - Kuwait 5
NG - Nigeria 5
AM - Armenia 4
BH - Bahrain 4
GA - Gabon 4
KH - Cambogia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
QA - Qatar 4
RS - Serbia 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 35.843
Salva come PNG Salva come JPEG
Città #
Singapore 2.304
Chandler 1.551
San Jose 1.488
Ashburn 1.429
Dublin 481
Jacksonville 459
Beijing 433
Ho Chi Minh City 378
San Mateo 369
New York 309
Hanoi 308
Nanjing 294
Milan 283
Jakarta 280
Ann Arbor 275
Los Angeles 274
Lauterbourg 272
Rome 264
Wilmington 244
Hefei 243
Tokyo 243
Munich 223
Hong Kong 202
Boston 195
Dearborn 187
Frankfurt am Main 170
Dallas 165
The Dalles 153
Woodbridge 153
Houston 148
Lawrence 141
Nürnberg 137
Moscow 135
Chicago 132
São Paulo 130
Cattolica 126
Marseille 119
Izmir 117
Boardman 116
Seattle 114
Redwood City 102
Lancaster 100
Helsinki 97
Princeton 95
Warsaw 94
Nanchang 89
Redmond 89
Santa Clara 85
Fairfield 83
Council Bluffs 78
Shenyang 74
Buffalo 71
Abidjan 70
Da Nang 69
Brussels 68
London 67
Norwalk 65
Kent 62
Cambridge 59
Hebei 59
Jiaxing 56
Mountain View 55
Rio de Janeiro 55
Hangzhou 54
Pune 54
Tianjin 54
Brooklyn 53
Orem 52
Shanghai 52
Seoul 51
University Park 51
Nuremberg 49
Haiphong 48
Changsha 47
Montreal 46
Bremen 45
Paris 45
Guangzhou 44
Kunming 43
Figino 42
St Louis 42
Amsterdam 41
Lappeenranta 41
Chennai 40
Denver 40
Johannesburg 40
Phoenix 40
Atlanta 39
Brasília 39
Baghdad 38
Leawood 38
Toronto 38
Vienna 38
Zhengzhou 35
Trieste 33
Belo Horizonte 31
Mexico City 31
Stockholm 31
Tashkent 31
Memphis 30
Totale 18.352
Salva come PNG Salva come JPEG
Nome #
Frameless stereotaxy in subthalamic deep brain stimulation: 3-year clinical outcome 676
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 365
The role of small intestinal bacterial overgrowth in Parkinson's disease 250
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 234
Heart Rate Variability during wake and sleep in Huntington's Disease patients. An observational, cross-sectional, cohort study 234
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 222
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 217
Difference in striatal dopamine transporter availability and psychiatric symptoms in Parkinson's disease subtypes: 123I-FP-CIT SPECT results 217
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 215
Patient's Loss of Empathy Is Associated With Caregiver Burden 208
Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 205
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 204
Assessment of neurological manifestations in hospitalized patients with COVID-19 198
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 197
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 195
Extradural motor cortex stimulation improves gait, speech, and language in a patient with pure akinesia 194
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease 191
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 189
Neuroacanthocytosis Syndromes in an Italian Cohort: Clinical Spectrum, High Genetic Variability and Muscle Involvement 189
Mutation screening of the DYT6/THAP1 gene in Italy 188
The left parietal lobe plays a role in the pathogenesis of blepharospasm? 186
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 185
Rehabilitation of hypomimia in Parkinson's disease: a feasibility study of two different approaches 185
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease 184
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 181
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 177
Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment 174
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 174
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 172
Emotional Awareness, Relationship Quality, and Satisfaction in Patients With Parkinson's Disease and Their Spousal Caregivers 172
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 172
Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study 171
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 169
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 169
Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia 169
Phenotypic characterisation of DYT13 primary torsion distonia. 168
Reliability of Clinical Diagnosis of Dystonia 167
Prevalence of spinocellulart ataxia type 2 mutation among ittalian Parkinsonian patients 166
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 165
Dopaminergic agents and nutritional status in Parkinson's disease 165
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 165
Atrofia multisistemica: correlazioni tra caratteristiche cliniche, prove di reflettività cardiovascolare e reperti di risonanza magnetica 164
Measuring gait quality in Parkinson’s disease through real-time gait phase recognition 163
Movement disorders in multiple sclerosis: Causal or coincidental association? 162
Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome 160
New olfactometric findings in Parkinson's disease 159
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 159
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. 158
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 158
Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa responsive parkinsonism 157
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 156
Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature 156
Dystonia gravidarum: a new case with a long follow-up 155
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 155
Transcranial magnetic stimulation predicts functional recovery after botulinum toxin treatment in stroke patients 155
Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families 155
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 153
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis 153
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 152
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 152
Clinical and genetic characteristics of late-onset Huntington's disease 152
Epidemiological, Clinical, and Molecular Study of a Cohort of Italian Parkinson Disease Patients: Association with Glutathione-S-Transferase and DNA Repair Gene Polymorphisms 151
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 151
Parkinson’s disease and virtual reality rehabilitation: cognitive reserve influences the walking and balance outcome 151
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability 150
Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview 150
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. 149
Working on asymmetry in Parkinson's disease: randomized, controlled pilot study 149
Use of ACE-inhibitors and falls in patients with Parkinson's disease 148
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 147
Blepharospasm with non-satisfactory response to treatment: Our experience with IncobotulinumtoxinA 146
Clinical differences between botulinum neurotoxin type A and B 145
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 144
Punding and computer addiction in Parkinson's disease 144
GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case 143
Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy 143
Early DEtection of wEaring off in Parkinson disease: the DEEP study 143
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 142
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 142
Analysis of blink rate in patients with blepharospasm 141
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up 140
Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia 140
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 140
Association of metabolic syndrome with falls in patients with Parkinson's disease 140
What about the caregiver? A journey into Parkinson’s disease following the burden tracks 140
Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. 139
Cardiac autonomic nervous system evaluation in Parkinson disease and multisystem atrophy 139
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 139
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 139
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease 139
Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis 138
Levodopa effect on electromyographic activation patterns of tibialis anterior muscle during walking in Parkinson's disease 138
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 137
Movement disorders following mechanical thrombectomy resulting in ischemic lesions of the basal ganglia: An emerging clinical entity 137
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease 137
Botulinum toxin injection for the treatment of chronic anal fissure: uni- and multivariate analysis of the factors that promote healing 137
Abnormal gating of somatosensory inputs in essential tremor. 136
Remission of functional motor symptoms following esketamine administration in a patient with treatmentresistant depression: A single-case report 136
Management of status dystonicus: our experience and review of the literature 135
DJ-1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7 135
Totale 17.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.899
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 0 0 0 0 0 39
2021/20222.131 188 215 58 116 110 67 38 313 82 153 327 464
2022/20234.483 523 589 355 602 337 528 238 351 645 90 161 64
2023/20242.319 86 663 77 159 90 307 145 151 34 67 252 288
2024/20254.977 104 171 409 152 383 199 207 254 762 431 1.057 848
2025/202614.012 1.941 420 840 1.412 2.134 684 2.529 887 897 1.183 525 560
Totale 36.385